| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PGEN | PRECIGEN INC | $4.21 | $4.25 | -0.85% | 32.38x | 17.54x | 9.61x | 18.01x | 0.34x | -$74.32M | -4.92% | $83.79M | 0.23 | $1.59B | 38.98 | ||
| CORT | CORCEPT THERAPEUTICS INC | $63.62 | $39.35 | 61.66% | 42.13x | 29.96x | 7.04x | 8.35x | 0.58x | $194.62M | 2.87% | $833.74M | 7.82 | $6.87B | 61.96 | ||
| TGTX | TG THERAPEUTICS INC | $63.34 | $20.29 | 212.17% | 81.21x | 61.79x | 9.93x | 16.73x | 1.12x | $85.56M | 0.96% | $572.13M | 4.06 | $9.90B | 50.40 | ||
| FENC | FENNEC PHARMACEUTICALS INC | $13.09 | $3.10 | 321.86% | 327.25x | 45.34x | 6.93x | 9.40x | 1.33x | $3.15M | 0.69% | $49.19M | 1.40 | $413.46M | 146.31 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $26.36 | $7.91 | 233.24% | 119.82x | 85.09x | 6.79x | 13.66x | 1.13x | $59.71M | 1.73% | $243.97M | 1.86 | $3.41B | 72.97 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $286.85 | $72.31 | 296.70% | 108.25x | 29.58x | 22.56x | 5.97x | 1.41x | $90.43M | 1.58% | $961.76M | 48.18 | $6.83B | 69.40 | ||
| KRYS | KRYSTAL BIOTECH INC | $308.89 | $76.44 | 304.09% | 40.33x | 39.42x | 19.46x | 6.38x | 2.23x | $310.08M | 3.39% | $1.44B | 48.48 | $8.70B | 32.76 | ||
| RPRX | ROYALTY PHARMA PLC | $68.45 | $34.70 | 97.27% | 44.74x | 12.51x | 11.67x | 4.01x | 0.73x | $2.89B | 9.48% | $9.80B | 21.96 | $47.34B | 45.37 | ||
| HALO | HALOZYME THERAPEUTICS INC | $91.35 | $74.11 | 23.26% | 21.54x | 10.09x | 5.77x | -188.54x | 0.50x | $885.88M | 8.52% | -$55.24M | -0.49 | $12.63B | 15.68 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $93.90 | $14.45 | 549.68% | 65.66x | 71.55x | 7.76x | 10.39x | 3.55x | $197.20M | 2.69% | $710.19M | 9.08 | $7.30B | 48.04 | ||
| VCEL | VERICEL CORP | $57.52 | $8.45 | 580.86% | 87.15x | 76.21x | 9.08x | 7.64x | 3.16x | $57.89M | 1.97% | $384.17M | 7.51 | $2.89B | 53.63 | ||
| ADMA | ADMA BIOLOGICS INC | $13.17 | $6.84 | 92.52% | 16.67x | 16.34x | 5.67x | 6.66x | 1.23x | $132.91M | 4.51% | $438.51M | 1.96 | $2.99B | 11.85 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $230.26 | $129.35 | 78.02% | 63.26x | 15.07x | 3.16x | 3.53x | 0.61x | $1.65B | 11.10% | $4.19B | 64.79 | $18.37B | 16.03 | ||
| TECH | BIO-TECHNE CORP | $72.67 | $16.00 | 354.30% | 66.06x | 34.99x | 9.28x | 5.27x | 1.97x | $308.20M | 2.71% | $2.17B | 13.81 | $11.35B | 34.01 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.76 | $7.85 | 11.59% | 6.90x | 7.67x | 3.52x | 2.18x | 1.32x | $87.07M | 16.74% | $238.92M | 4.02 | $400.34M | 4.16 | ||
| INCY | INCYTE CORP | $114.63 | $52.75 | 117.30% | 54.84x | 33.21x | 3.88x | 4.14x | 0.79x | $684.87M | 2.94% | $5.64B | 27.76 | $20.12B | 22.43 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $515.02 | $144.01 | 257.63% | 32.87x | 27.71x | 10.08x | 6.25x | 2.14x | $3.20B | 2.45% | $20.91B | 82.48 | $132.08B | 26.23 | ||
| EXEL | EXELIXIS INC | $64.63 | $31.25 | 106.80% | 18.73x | 18.46x | 6.39x | 8.60x | 1.25x | $1.16B | 7.28% | $1.83B | 7.43 | $15.63B | 13.98 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $920.69 | $484.63 | 89.98% | 19.58x | 13.11x | 5.54x | 2.84x | 1.02x | $3.83B | 4.09% | $33.50B | 329.39 | $94.29B | 15.10 | ||
| UTHR | UNITED THERAPEUTICS CORP | $554.73 | $208.59 | 165.94% | 19.42x | 20.72x | 7.43x | 3.76x | 2.16x | $867.20M | 3.66% | $6.28B | 146.98 | $22.44B | 13.89 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $32.59 | $28.06 | 16.12% | 10.55x | 8.50x | 1.92x | 1.78x | 0.70x | $322.93M | 16.97% | $1.07B | 18.36 | $1.42B | 5.22 | ||
| VCYT | VERACYTE INC | $25.13 | $9.57 | 162.46% | 15.81x | 12.83x | 3.48x | 1.41x | 3.38x | $161.95M | 8.01% | $1.43B | 17.80 | $1.87B | 13.09 |